(Q37700555)

22 August 2017

1 reference

title

Treatment options for multidrug-resistant nonfermenters (English)

1 reference

22 August 2017

main subject

multiple drug resistance

1 reference

David Felipe Briceño

1

1 reference

22 August 2017

John P Quinn

series ordinal

2

1 reference

22 August 2017

María Virginia Villegas

series ordinal

3

1 reference

22 August 2017

publication date

1 March 2010

1 reference

Expert Review of Anti-infective Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

303-315

1 reference

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Optimal use of antibiotic resistance surveillance systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Resistance patterns among nosocomial pathogens: trends over the past few years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Pseudomonas aeruginosa - a phenomenon of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular basis of bacterial outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

The structure of β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Emergence of SHV-2a extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a university hospital in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Metallo-beta-lactamases: the quiet before the storm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Mechanistic characterization of the bifunctional aminoglycoside-modifying enzyme AAC(3)-Ib/AAC(6')-Ib' from Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

aph(3')-IIb, a gene encoding an aminoglycoside-modifying enzyme, is under the positive control of surrogate regulator HpaA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Emerging mechanisms of fluoroquinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Mechanism of plasmid-mediated quinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Mechanisms of resistance to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antimicrobial resistance of Acinetobacter spp. in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Acinetobacter baumannii: emergence of a successful pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antimicrobial resistance among and therapeutic options against gram-negative pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Doripenem: antimicrobial profile and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Sulbactam-containing beta-lactamase inhibitor combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Extensively drug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Acinetobacter baumannii: a universal threat to public health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

21 January 2018

Acinetobacter infection

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Nephrotoxicity of colistin: new insight into an old antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Update on the treatment of Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

21 January 2018

Parenteral carbapenems

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Health care-associated pneumonia: identification and initial management in the ED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

Boosting antimicrobial peptides by hydrophobic oligopeptide end tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.125

21 January 2018

Identifiers

DOI

10.1586/ERI.09.125

1 reference

22 August 2017

1 reference